Head of DMPK & Toxicology
Team
Manfred Schneider serves as Head of DMPK and Toxicology at FundaMental Pharma.
He has experience working in Biotech and large Pharma with a track record that includes the support of two IPOs as well as several successful Series A to C financing rounds totaling more than $300 Mio.
Manfred has more than 25 years of international experience in his field working for 10 years in the United States at Tularik (now Amgen) in San Francisco and at Forest Laboratories in New York City, the latter during the memantine drug approval for AD.
Between 2006 and 2012 he held positions in Europe as Head of DMPK and Toxicology (Addex and Merck Serono; both Geneva, Switzerland). He has been an independent consultant since 2013.
Manfred Schneider holds a Masters Diploma (MSc) and PhD in Chemistry from the University of Ulm, Germany. He has authored over 20 peer reviewed scientific articles and is an inventor of multiple granted and pending patents.
